The GAPP Project is funded by the EU-FP7 with the aim to improve the quality of life in children affected by chronic pain. These patients are treated in most cases with drugs which are not authorised for paediatric use. Participants will conduct controlled clinical trials investigating dosage, efficacy and safety of gabapentin for the treatment of paediatric pain.
On June 30 and July 1, 2016, the 4th General Assembly meeting took place in Rotterdam, the Netherlands, with the participation of the whole GAPP Consortium. The […] Read more
Please subscribe to the GAPP Project newsletter to receive our latest updates.